New study finds pregnant women with glucose intolerance at risk of heart disease
ONTARIO, Canada Mild glucose intolerance in pregnancy may be an early identifier of women who are at increased risk of heart disease in the future, found a new study published in the Canadian Medical Association Journal.
In a large population-based cohort study, researchers from the University of Toronto and the Institute for Clinical Evaluative Sciences studied data on 435,696 women in Ontario, Canada, who gave birth between April, 1994 and March, 1998. All women were followed until March 31, 2008. The study excluded women with pre-existing diabetes.
“Women who had an abnormal glucose challenge test but then did not have gestational diabetes had an increased risk of future cardiovascular disease, compared to the general population, but a lower risk than women who actually did have gestational diabetes,” stated Baiju Shah, Institute for Clinical and Evaluative Sciences and coauthor.
Therefore, current screening procedures for gestational diabetes might also provide a means for the early identification of women who are at risk for developing heart disease later in life.
NPA criticizes remarks tying dietary supplements to tainted products
WASHINGTON The Natural Products Association on Thursday released a statement criticizing the erroneous link between legitimate dietary supplements and tainted products. “Increased scrutiny by professional sports leagues on steroid usage, which the Natural Products Association commends, has unfortunately also led to increased and unsubstantiated allegations that a ‘tainted’ or mislabeled dietary supplement is to blame when an athlete tests positive for a banned substance,” said David Seckman, NPA executive director and CEO.
“As the Dietary Supplement Health and Education Act of 1994 mandates, all ingredients must be listed on product labels and product claims must be substantiated. If this is not the case, the U.S. Food and Drug Administration—along with the Federal Trade Commission—have the authority under DSHEA to act promptly,” he said.
Seckman also noted that not all substances banned by professional sports organizations as performance enhancers are either bad or illegal. “Performance enhancers [that] are not necessarily dangerous or illegal … include caffeine, commonly used over-the-counter cold remedies and prescription medications,” he said. “Athletes have the right and responsibility to avoid their use. However, the consuming public who benefits from legitimate medications or dietary supplements – as well as a trip to the local coffee house – should not be denied their use if an athlete is unwilling or unable to follow the rules established by their sport.”
CRN names new members
WASHINGTON The Council for Responsible Nutrition on Monday named four new members to its roster, including Polyphenolics of Madera, Calif.; SourceOne Global Partners, of Chicago; Vifor Pharma of St. Gallen, Switzerland; and Summit Environmental Technologies of Cuyahoga Falls, Ohio.
Polyphenolics is a division of Constellation Wines U.S. that provides natural nutritional ingredients that can be produced from grapes.
SourceOne Global Partners is a supplier of innovative, science-based, branded ingredients and proprietary formulas to the nutritional supplement, functional food, beverage, cosmetics and animal nutrition markets.
Vifor Pharma is a fully integrated company within the Galencia Group, which researches, develops, produces and markets pharmaceutical and nutraceutical products throughout the world. The company supplies customers in approximately 80 countries with finished products and active compounds as well as oral and parenteral iron preparations.
Summit Environmental Technologies provides environmental analytical laboratory testing services to consultants, manufacturing plants, waste disposal faculties, paper mills and wastewater plants nationwide to ensure improved quality.